PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

46,701 stories, page 758 of 779

Advanced search
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 2026

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

EMA recommends authorisation of veterinary vaccine for lumpy skin disease in cattle | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

EMA recommends authorisation of Rasonque for metastatic pancreatic cancer | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

EMA Management Board: highlights of September 2026 meeting | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

Clinical trial applications advice pilot becomes permanent | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

AMA and EMA issue joint guidance on Ebola vaccine development | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source
🇪🇺Regulatoryema.europa.euTier 1 · Regulatory source

Advice on ‘end-of-year’ submission dates for type I variations in 2026

EMA Human MedicinesOriginal source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Towards a Single Regulatory Pathway for AI-Enabled Medical Technologies

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Patient safety: EAHP & EFPIA publish joint guidance on single unit barcoding

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Overweight and obesity linked to 278,000 deaths and the loss of 8 million years of healthy life in 8 European countries

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA supports progress towards public procurement that rewards quality and innovation

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA Statement on the Cloud and AI Development Act (CADA)

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA calls for pause in Urban Wastewater Treatment Directive implementation amid growing concerns from EU Member States

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Commission’s recommendation on health checks important first step towards managing cardiovascular disease for all Europeans

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Why cardiovascular health checks: The case for EU action

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Impact of Innovative Medicines/Health Initatives projects on rare diseases

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA submission to the EU Biotech Act consultation

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA response to the General Court ruling on the Urban Wastewater Treatment Directive

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA response to EC targeted revision MDR/IVDR – “Have your say”

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

EFPIA and Vaccines Europe (VE) submission to the Call for Evidence for the EU Biotech Act II

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

A comparative analysis of biopharmaceutical strategies in 10 countries

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

World Patient Safety Day: Safer medicines start long before you take them (Guest blog)

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Why Europe needs to rethink health security? (Guest blog)

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Putting people with Alzheimer’s disease at the centre of their healthcare journey

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

From approval to access: Why uptake of new cancer medicines still varies across Europe (Guest blog)

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

Alzheimer's disease can't wait: the economic case for Europe to act now (Guest blog)

EFPIA (European Pharma Industry)Original source
🇪🇺Associationefpia.euTier 2 · Direct publisher

The EFPIA view

EFPIA (European Pharma Industry)Original source
🌍Industryeastchinapharm.comTier 1 · Company source

2026/08/12 公司新闻 华东医药生命科学产业园（河东区块）技术改造项目环境保护设施竣工及调试日期公示

Huadong MedicineOriginal source
🌍Industryeastchinapharm.comTier 1 · Company source

2026/06/16 公司新闻 防非宣传月｜拒绝非法荐股诱惑，筑牢理性投资防线

Huadong MedicineOriginal source
🌍Industryeastchinapharm.comTier 1 · Company source

2026/06/15 公司新闻 “制剂开发部中药实验室场地改造项目”环境保护设施竣工及调试日期延期公示

Huadong MedicineOriginal source
🌍Industryeastchinapharm.comTier 1 · Company source

2026/05/11 公司新闻 华东医药Ellansé®伊妍仕®M型（商品名：伊妍仕恒耀™）注册申请获得上市批准

Huadong MedicineOriginal source
🌍Industryeastchinapharm.comTier 1 · Company source

2026/05/11 公司新闻 华东医药司美格鲁肽注射液体重管理适应症上市申请获NMPA受理

Huadong MedicineOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Industrial Wastewater Treatment | DuPont Water Solutions

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Industrial Utility Water Treatment | DuPont Water Solutions

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont Wins R&D 100 Award for Innovation in Healthcare

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont Publishes 2026 Sustainability Report

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont Net-Zero Climate Targets Validated by Science Based Targets initiative

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont™ MemCor™ MBR system selected for major Riverstone Water Resource Recovery Facility upgrade in Australia

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

DuPont Direct Lithium Extraction Team Named 2026 Sustainability Squad by Business Intelligence Group

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Australia’s Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

2025 Archive

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

2024 Archive

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

2023 Archive

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Packaging & Printing Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Healthcare, Medical & Pharmaceutical Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Government & Public Sector Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Food & Beverage Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Fashion & Textiles Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Electronics Fabrication & Testing Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Devicesdupont.comTier 1 · Company source

Building & Construction Industry Solutions | DuPont

DuPontOriginal source
🇺🇸Industrydnanexus.comTier 1 · Company source

DNAnexus Named to the 2026 Inc. 5000 List, the Most Prestigious Ranking of America’s Fastest-Growing Private Companies

DNAnexusOriginal source
🇺🇸Industrydnanexus.comTier 1 · Company source

DNAnexus Customer Satisfaction Reaches 90% Amid Platform Expansion Into AI-Driven Discovery

DNAnexusOriginal source
🇺🇸Industrydnanexus.comTier 1 · Company source

CariGenetics Partners with DNAnexus to Launch First Caribbean Collaborative Genomics Research Infrastructure with NVIDIA

DNAnexusOriginal source
🇩🇪Researchdkfz.deTier 2 · Direct publisher

Vermietung von Konferenz­räumlichkeiten

German Cancer Research Center (DKFZ)Original source
🇩🇪Researchdkfz.deTier 2 · Direct publisher

Themen im Fokus

German Cancer Research Center (DKFZ)Original source
🇩🇪Researchdkfz.deTier 2 · Direct publisher

einblick – Das DKFZ-Magazin

German Cancer Research Center (DKFZ)Original source